PTP1b: A promising and challenging target for metabolic disease

International Journal of Pharmacology

Volumn 2, Issue 1, 2006, Pages 93-97

  Zhang, Yan Ling ^a   Tobin, James F ^a   Erbe, David V ^a  

^a PFIZER INC   (United States)

Author keywords

Insulin diabetes; Insulin resistance; Leptin; Protein tyrosine phosphatases; PTP1b; Signal transduction

Indexed keywords

INSULIN; LEPTIN; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR;

ARTICLE; BINDING SITE; DRUG DESIGN; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG STRUCTURE; DRUG TARGETING; GENE TARGETING; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYSICAL CHEMISTRY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

EID: 33644543443     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2006.93.97     Document Type: Article

References (38)

1. Zimmel, P., K.M. Alberti and J. Shaw, 2001. Global and societal implications of the diabetes epidemic. Nature, 414: 782-787.
2. Flier, J.S., 2004. Obesity wars: Molecular progress confronts an expanding epidemic. Cell, 116: 337-350.
3. Willson, T.M., P.J. Brown, D.D. Stembach and B.R. Henke, 2000. The PPARs: From orphan receptors to drug discovery. J. Med. Chem., 43: 527-550.
4. Rosen, E.D. and B.M. Spiegelman, 2001. PPAR-γ: A nuclear regulator of metabolism, differentiation and cell growth. J. Biol. Chem., 276: 37731-37734.
5. Inzucchi, S.E., 2002. Oral antihyperglycemic therapy for type 2 diabetes: Scientific review. JAMA., 287: 360-372.
6. Mudaliar, S. and R.R. Henry, 2001. New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers. Ann. Rev. Med., 52: 239-259.
7. Yki-Jarvinen, H., 2004. Thiazolidinediones. N. Engl. J. Med., 351: 1106-1118.
8. Nesto, R.W., D. Bell, R.O. Bonow, V. Fonseca and S.M. Grundy et al., 2003. Thiazolidinedione use, fluid retention and congested heart failure. Circulation, 108: 2941-2948.
9. Diamant, M. and R.J. Heine, 2003. Thiazolidinediones in type 2 diabetes mellitus: Current clinical evidence. Drugs, 63: 1373-1405.
10. Hunter, T., 2000. Signaling-2000 and beyond. Cell, 100: 113-127.
11. Saltiel, A.R. and C.R. Kahn, 2001. Insulin signaling and the regulation of glucose and lipid metabolism. Nature, 414: 799-806.
12. Cheng, A., N. Uetani, P.D. Simoncic, V.P. Chaubey and A. Lee-Loy et al., 2002. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev. Cell, 2: 385-387.
13. Elchebly, M., P. Payette, E. Michaliszyn, W. Cromlish and S. Collins et al., 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1b gene. Science, 283: 1544-1548.
14. Klaman, L.D., O. Boss, O.D. Peroni, J.K. Kim and J.L. Martino et al., 2000. Increased energy expenditure, decreased adiposity and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1b-deficient mice. Mol. Cell. Biol., 20: 5479-5489.
15. Zabolotny, J.M., K.K. Bence-Hanulec, A. Stricker-Krongrad, F. Haj and Y. Wang et al., 2002. PTP1B regulates leptin signal transduction in vivo. Dev. Cell, 2: 489-495.
16. Gu, F., N. Dube, J.W. Kim, A. Cheng, M. de Jesus Ibarra-Sanchez, M.L. Tremblay and Y.R. Boisclair, 2003. Protein tyrosine phosphatase 1b attenuates growth hormone-mediated jak-stat signaling. Mol. Cell. Biol., 23: 3753-3762.
17. Dube, N., A. Cheng and M.L. Tremblay, 2004. The role of protein tyrosine phosphatase 1B in Ras signaling. PNAS, 101: 1834-1839.
18. Zinker, B.A., C.M. Rondinone, J.M. Trevillyan, R.J. Gum and J.E. Clampit et al., 2002. PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose and improves insulin sensitivity in diabetic mice. PNAS, 99: 11357-11362.
19. Gum, R.J., L.L. Gaede, S.L. Koterski, M. Heindel and J.E. Clampit et al., 2003. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes, 52: 21-28.
20. Bhanot, S., M. Butler, S. Booten, R. Mckay, S. Murray, B.P. Monia, T.W. Beck and A.A. Levin, 2002. Effects of a novel PTP1B antisense inhibitor (ISIS 113715) in cynomologous monkeys. Diabetes Mellitus: Molecular Mechanisms, Genetics and New Therapies, Keystone, CO.
21. Tonks, N.K., 2003. PTP1B: From the sidelines to the frontlines. FEBS Lett., 546: 140-148.
22. Van Huijsduijnen, R.H., W.H.B. Sauer, A. Bombrun and D. Swinnen, 2004. Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs. J. Med. Chem., 47: 4142-4146.
23. Barford, D., A.J. Flint and N.K. Tonks, 1994. Crystal structure of human protein tyrosine phosphatase 1B. Science, 263: 1397-1404.
24. Pedersen, A.K., G.H. Peters, K.B. Moller, L.F. Iversen and J.S. Kastrup, 2004. Water-molecule network and active-site flexibility of apo protein tyrosine phosphatase 1B. Acta Cryst., D60: 1527-1534.
25. Jia, Z., D. Barford, A.J. Flint and N.K. Tonks, 1995. Structure basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science, 268: 1754-1758.
26. Sun, J.P., A.A. Fedorov, S-Y. Lee, X.L. Guo, K. Shea, D.S. Lawrence, S.C. Almo and Z.Y. Zhang, 2003. Crystal Structure of PTP1B complexed with a potent and selective bidentate inhibitor. J. Biol. Chem., 278: 12406-12414.
27. Iversen, L.F., H.S. Andersen, S. Branner, S.B. Mortensen, G.H. Peters and K. Norris et al., 2000. Structure-Based design of a low molecular weight, nonphosphorus, nonpeptide and highly selective inhibitor of protein-tyrosine phosphatase 1B. J. Biol. Chem., 275: 10300-10307.
28. Zhang, Y.L. and Z.Y. Zhang, 1998. Low-affinity binding determined by titration calorimetry using a high-affinity coupling ligand. Anal. Biochem., 261: 139-148.
29. Wang, F., W. Li, M.L. Emmelt, C.L. Hendrickson, A.G. Marchall, Y.L. Zhang, L. Wu and Z.L. Zhang, 1998. Conformational and dynamic changes of yersinia protein tyrosine phosphatase induced by ligand binding and active site mutations revealed by H/D exchange and electrospray ionization fourier transform ion cyclotron reassurance mass spectrometry. Biochemistry, 37: 15289-15299.
30. Zhang, Y.L., Z.J. Yao, M. Sarmiento, L. Wu, T.R. Burke and Z.Y. Zhang, 2000. Thermodynamic study of ligand binding to protein-tyrosine phosphatase 1B and its substrate-trapping mutants. J. Biol. Chem., 275: 34205-12.
31. Puius, Y.A., Y. Zhao, M. Sullivan, D.S. Lawrence, S.C. Almo and Z.Y. Zhang, 1997. Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor design. Prococeeding of National Academy of Science, 94: 13420-13425.
32. Tobin, J.F. and S. Tam, 2002. Recent advances in the development of small molecule inhibitors of PTP1b for the treatment of insulin resistance and type 2 diabetes. Curr. Opin. Drug Dicov. Dev., 5: 500-512.
33. Johnson, T.O., J. Ermolieff and M.R. Jirousek, 2002. Protein tyrosine phosphatase 1B inhibitors for diabetes. Natl. Rev. Drug Disc., 1: 696-709.
34. Moller, N.P.H., L.F. Iversen, H.S. Andersen and J.G. McCormack, 2000. Protein tyrosine phosphatases (PTPs) as drug targets: Inhibitors of PTP-1b for the treatment of diabetes. Curr. Opin. Drug Discov. Dev., 3: 527-540.
35. Doman, T.N., S.L. McGovern, B.J. Witherbee, T.P. Kasten, R. Kurumbail, W.C. Stallings, D.T. Connolly and B.K. Shoichet, 2002. Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J. Med. Chem., 45: 2213-2221.
36. McGovern, S.L., E. Caselli, N. Grigorieff and B.K. Shoichet, 2002. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J. Med. Chem., 45: 1712-1722.
37. Erbe, D.V., S. Wang, Y.L. Zhang, K. Harding and L. Kung et al., 2005. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. Mol. Pharm., 67: 69-77.
38. Weismann, C., K.J. Barr, J. Kung, J. Zhu and D.A. Erlanson et al., 2004. Allosteric inhibition of protein tyrosine phosphatase 1B. Natl. Struct. Mol. Biol., 11: 730-737.